Innate Pharma
IPHA
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)
Categories
Innate Pharma (IPHA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.14 B
According to Innate Pharma 's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Innate Pharma - Total liabilities on balance sheet (from 2009 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.16 B | -9.18% |
| 2021-12-31 | $0.18 B | -2.69% |
| 2020-12-31 | $0.18 B | -9.6% |
| 2019-12-31 | $0.20 B | -36.57% |
| 2018-12-31 | $0.32 B | 60.06% |
| 2017-12-31 | $0.20 B | -1.33% |
| 2016-12-31 | $0.20 B | -19.56% |
| 2015-12-31 | $0.25 B | 1208.96% |
| 2014-12-31 | $19.53 M | -9.29% |
| 2013-12-31 | $21.53 M | -34.69% |
| 2012-12-31 | $32.97 M | -24.01% |
| 2011-12-31 | $43.39 M | 125.09% |
| 2010-12-31 | $19.27 M | -21.29% |
| 2009-12-31 | $24.49 M | -10.24% |
| 2008-12-31 | $27.29 M | 37.97% |
| 2007-12-31 | $19.78 M | 16.12% |
| 2006-12-31 | $17.03 M | 206.63% |
| 2005-12-31 | $5.55 M |